Global Immunoglobulins Report Thumbnail

Global Immunoglobulins Market by Type (IgG, IgA, IgM, IgE, IgD), By Application (Hospital, Research) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-698
  • Author: Up Market Research
  • Rating: 4.9
  • Total Reviews: 54
  • No. Of Pages: 247
  • Format:
  • Pub. Date: 2021-03-01
  • Share:

The Global Immunoglobulins Market size is expected to grow at a CAGR of 6.4%, during the forecast period (2021-2028), and reach USD 29.2 billion by 2028 from USD 18.6 billion in 2016. This growth will be primarily driven by the rising demand for immunoglobulin therapy for multiple autoimmune disorders such as rheumatoid arthritis. The increasing prevalence of chronic infections due to increased resistance among bacteria against antibiotics is also contributing towards the growth.


An immunoglobulin is a large protein molecule, typically produced by the immune system. Immunoglobulins form an important part of the immune response to infections and other diseases or injuries. They are also used as a medication for allergies, inflammatory bowel disease, multiple sclerosis, etc.

Immunoglobulins can be synthesized (produced by the body) or animal-derived, which includes human serum globulin and embryo papain inactivated adsorbed immunoglobulin; they are used for preventing infections from bacteria like Streptococcus pneumonia, Haemophilus influenzae type B, and Salmonella typhi as well as viral diseases such as chickenpox, hepatitis A and measles. They also are found in many vaccines including diphtheria toxoid, rabies vaccine, and tetanus vaccine – this helps protect against developing these illnesses that may lead to death if left untreated.


On the basis of Types, the market is segmented into IgG (gamma-globulin), IgA (alpha-globin), IgM(mu - globulin), and IgE.


IgG (gamma-globulin):

IgG is a partition of the immunoglobulin G (IgG) class. IgGs are one-third of all serum proteins and half of that in the bloodstream, making them the most common type. These molecules are also important for immunity: they interact with invading cells by binding to their surfaces as lectins or antibodies do, but instead of tagging these invaders for destruction, IgGs tag pathogens to make it easier for other immune components such as mast cells and phagocytes to recognize them.


IgA (alpha-globin):

Immunoglobulins are a type of protein produced by plasma cells and monocytes that recognize specific antigens. IgA is the most abundant immunoglobulin in body fluids, found on mucosal surfaces such as those lining the respiratory tract or intestines. It provides immunity to bacteria, viruses, fungi, and other foreign organisms from inside our bodies by binding these harmful substances with antibodies that neutralize them before they can do any harm. This protective mechanism also applies to food particles (proteins) eaten in order for us to absorb nutrients properly.

In addition, IgA helps regulate inflammatory reactions throughout the immune system because it contains an enzyme called Amyloid A which prevents inflammation when released into blood vessels. Hence, this immunoglobulin protects the body from both infections and inflammation.


IgM(mu - globulin):

IgM is the major immunoglobulin in human colostrum and breast milk. IgM is the third most common immunoglobulin in serum and consists of two different heavy chains. It is primarily found on plasma cells, macrophages, and B-cells; it plays a key role in immunity to protozoans. IgM antibodies can neutralize toxins by binding their receptors or block infection by coating viruses with antibody molecules that identify them for destruction.


IgE Immunoglobulin:

IgEs, or immunoglobulin E, is a subset of antibodies that help defend against environmental substances and microbes like bacteria and viruses. These specialized cells work by binding to molecules outside the body called allergens which can cause allergic reactions when they come into contact with the skin or respiratory system. In most cases, there will be an immediate reaction (wheezing/asthma) but it may take hours for symptoms to occur; this time period between stimulation and symptom increase due to secondary exposure where sensitization occurs through re-exposure. Treatment usually involves medications such as antihistamines, decongestants, inhalers, steroids, etc.


On the basis of Application, the market is segmented into Hospital and Research.



The Immunoglobulin market in the hospitals can be attributed to factors such as increasing number of patients with allergies; rising geriatric population resulting in higher prevalence of chronic diseases like asthma; growing incidence rate for allergic rhinitis which are linked to immunoglobulins deficiency; extensive research on innovative ways to treat allergies by using immunoglobulin therapy drugs etc.



Immunoglobulin is used in research for a variety of purposes. Immunoglobulins are often put into vaccines to stimulate antibody production and immunity against diseases like tetanus or hepatitis A, which use the immune system’s B cells to identify invading bacteria and viruses respectively. In animal studies, immunoglobulins can be added to healthy animals as a way of measuring response rates from other treatments being tested on these animals.


On the basis of Region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The US dominates the North American Immunoglobulins Market owing to the availability of various types at affordable cost with a short turnaround time from suppliers. Canada’s desirability creates an opportunity for manufacturers to explore their potential share in this field by concentrating more on manufacturing facilities there). However, it has a relatively small population and it is difficult to encourage patients to undergo a health screening.

Many players are focusing on the Asia Pacific region due to technological advancements in this market as well as an increasing need for immunoglobulin therapy drugs. Light competition between leading players that focuses on innovative treatments and novel applications will drive the growth of this regional market over the coming years.


Up Market Research published a new report titled “Immunoglobulins Market research report which is segmented by Types (IgG, IgA, IgM, IgE, IgD), By Applications (Hospital, Research), By Players/Companies Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics,, BioScrip”. 


Report Scope

Report Attributes Report Details
Report Title Immunoglobulins Market Research Report
By Type IgG, IgA, IgM, IgE, IgD
By Application Hospital, Research
By Companies Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics,, BioScrip
Regions Covered North America, Europe, APAC, Latin America, MEA
Base Year 2020
Historical Year 2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year 2028
Number of Pages 247
Number of Tables & Figures 173
Customization Available Yes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Immunoglobulins Industry Outlook

Global Immunoglobulins Market Report Segments:

The market is segmented by Type IgG, IgA, IgM, IgE, IgD and By Application Hospital, Research.


Some of the companies that are profiled in this report are:

  1. Hualan Biological Engineering Inc.
  2. Omrix Biopharmaceuticals Ltd.
  3. Behring GmbH
  4. Shanghai RAAS Blood Products
  5. Option Care Enterprises
  6. ADMA Biologics,
  7. BioScrip

Immunoglobulins Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Immunoglobulins Market

Overview of the regional outlook of the Immunoglobulins Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Immunoglobulins Market Overview

Highlights of The Immunoglobulins Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Immunoglobulins Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. IgG

                2. IgA

                3. IgM

                4. IgE

                5. IgD

       7. By Application:

                1. Hospital

                2. Research

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Immunoglobulins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Immunoglobulins Market Statistics

Reasons to Purchase the Immunoglobulins Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Immunoglobulins Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Immunoglobulins Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Immunoglobulins Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Immunoglobulins Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Immunoglobulins Market Size & Forecast, 2018-2028 
      4.5.1 Immunoglobulins Market Size and Y-o-Y Growth 
      4.5.2 Immunoglobulins Market Absolute $ Opportunity 

Chapter 5 Global Immunoglobulins Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Immunoglobulins Market Size Forecast by Type
      5.2.1 IgG
      5.2.2 IgA
      5.2.3 IgM
      5.2.4 IgE
      5.2.5 IgD
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Immunoglobulins Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Immunoglobulins Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Research
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Immunoglobulins Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Immunoglobulins Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Immunoglobulins Analysis and Forecast
   9.1 Introduction
   9.2 North America Immunoglobulins Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Immunoglobulins Market Size Forecast by Type
      9.6.1 IgG
      9.6.2 IgA
      9.6.3 IgM
      9.6.4 IgE
      9.6.5 IgD
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Immunoglobulins Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Research
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Immunoglobulins Analysis and Forecast
   10.1 Introduction
   10.2 Europe Immunoglobulins Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Immunoglobulins Market Size Forecast by Type
      10.6.1 IgG
      10.6.2 IgA
      10.6.3 IgM
      10.6.4 IgE
      10.6.5 IgD
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Immunoglobulins Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Research
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Immunoglobulins Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Immunoglobulins Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Immunoglobulins Market Size Forecast by Type
      11.6.1 IgG
      11.6.2 IgA
      11.6.3 IgM
      11.6.4 IgE
      11.6.5 IgD
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Immunoglobulins Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Research
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Immunoglobulins Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Immunoglobulins Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Immunoglobulins Market Size Forecast by Type
      12.6.1 IgG
      12.6.2 IgA
      12.6.3 IgM
      12.6.4 IgE
      12.6.5 IgD
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Immunoglobulins Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Research
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Immunoglobulins Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Immunoglobulins Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Immunoglobulins Market Size Forecast by Type
      13.6.1 IgG
      13.6.2 IgA
      13.6.3 IgM
      13.6.4 IgE
      13.6.5 IgD
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Immunoglobulins Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Research
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Immunoglobulins Market: Competitive Dashboard
   14.2 Global Immunoglobulins Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Hualan Biological Engineering Inc.
      14.3.2 Omrix Biopharmaceuticals Ltd.
      14.3.3 Behring GmbH
      14.3.4 Shanghai RAAS Blood Products
      14.3.5 Option Care Enterprises
      14.3.6 ADMA Biologics,
      14.3.7 BioScrip
Segments Covered in the Report
The global Immunoglobulins market has been segmented based on

By Types
  • IgG
  • IgA
  • IgM
  • IgE
  • IgD
By Applications
  • Hospital
  • Research
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Hualan Biological Engineering Inc.
  • Omrix Biopharmaceuticals Ltd.
  • Behring GmbH
  • Shanghai RAAS Blood Products
  • Option Care Enterprises
  • ADMA Biologics,
  • BioScrip

Buy Report